novel palladium complex: cytotoxicity against cisplatin-resistant k562 cells

Today, development of resistance to anticancer drugs (including cisplatin) is noticed as a major problem. recently several studies demonstrated that palladium complexes showed remarkable cytotoxic effects against k562 cell line and could be used efficiently for treatment of many human cancers including leukemia. hereof, k562 cells were made resistant to cisplatin using increasing concentration of cisplatin up to 4.5, and then cytotoxic effect of synthesized palladium complex was evaluated on this subline using mtt assay. annexin v/pi staining using flow cytometry and scanning electron microscopy (sem) were performed to find out the mechanism of the observed cytotoxicity. results indicated that tested compounds had a noticeable cytotoxic effect on k562 cells 80 times more than cisplatin. palladium complex also showed significant cytotoxicity on resistant k562 subline. flow cytometry and sem results revealed that these compounds exert their cytotoxic effect via apoptosis and it could be concluded that the novel synthesized palladium complex might be a good candidate for replacing cisplatin in case of treatment of cisplatin resistant tumors.